Newtag icon
Top Black Friday 2025 brands announced! What were the hottest products and categories?Download the report now 👉banner icon

davaindia GENERIC PHARMACY analisi dell'app per 9 dicembre

davaindia GENERIC PHARMACY

davaindia GENERIC PHARMACY

  • davaindia
  • Google Play Store
  • Gratis
  • Settore Medico
The DavaIndia mobile app is a platform designed to provide users with affordable healthcare solutions through generic medicines. The app is an extension of DavaIndia, a leading chain of generic pharmacy stores in India. It aims to make healthcare accessible and affordable by offering high-quality generic medicines at significantly lower prices than branded medicines. Here's an overview of the app's features: Key Features: Wide Range of Medicines: Access to over 2,000 FDA-approved generic medicines, including categories like medicine, over-the-counter (OTC) products, wellness products, and healthcare essentials. Options for diseases management, acute conditions, and preventive care. Search and Order: User-friendly search to find medicines by name, salt, or category. Easy online ordering for home delivery or store pickup. Medicine Substitutes: Allows users to check for cheaper, generic alternatives to branded medicines with the same composition. Services: Provides access to expert pharmacist for dosage, ensuring users receive the right advice for their health conditions. Discounts and Savings: Offers substantial savings, typically ranging from 30-90% compared to branded medicines. Regular deals, cashback offers, and discounts for registered users. Store Locator: Integrated map to locate the nearest DavaIndia pharmacy for in-store purchases. Health Management Tools: Features like pill reminders, health tips, and wellness trackers to help users manage their health proactively. Secure and Easy Payments: Multiple payment options, including UPI, wallets, credit/debit cards, and cash on delivery. User Profiles and History: Personalized accounts to save medical history, past orders for easy reordering. Customer Support: 24/7 customer assistance to resolve queries related to orders or healthcare advice. Benefits: Affordable healthcare solutions. Convenient access to medicines. Transparency in medicine pricing and availability. The Davaindia app simplifies the process of purchasing medicines, making it ideal for users who prioritize affordability and convenience. It bridges the gap between quality healthcare and cost-effectiveness in India.
davaindia GENERIC PHARMACY

Ranking di utilizzo di davaindia GENERIC PHARMACY

Il ranking di utilizzo si basa sull'algoritmo di Similarweb che calcola le installazioni correnti e gli utenti attivi su un periodo di 28 giorni.

Tutte le categorie in
Stati Uniti--
Settore Medico in
Stati Uniti--

Utenti attivi giornalieri

Analizza i modelli di utilizzo degli utenti di davaindia GENERIC PHARMACY visualizzando i download di davaindia GENERIC PHARMACY e gli utenti attivi giornalieri nel tempo.

Utenti

Analizza i modelli di utilizzo degli utenti di davaindia GENERIC PHARMACY visualizzando i download di davaindia GENERIC PHARMACY e gli utenti attivi giornalieri nel tempo.

Unlock daily active users
ottnov9ic

davaindia GENERIC PHARMACYStatistiche di ranking nel tempo

Classifica di Utilizzo di Similarweb e Classifica Google Play Store per davaindia GENERIC PHARMACY

Rank

Nessun dato disponibile

davaindia GENERIC PHARMACY Classifica per paese

Paesi in cui davaindia GENERIC PHARMACY ha la posizione più alta nelle sue categorie principali


Interessi degli utenti e categorie principali

Le categorie principali e le app utilizzate dagli utenti di davaindia GENERIC PHARMACY

Nessun dato da visualizzare

Principali concorrenti e app alternative

App con un'alta probabilità di essere utilizzate dagli stessi utenti, provenienti dallo stesso store.

myAster

myAster

Aster DM Healthcare FZC

Zoho Projects

Zoho Projects

Zoho Corporation

Zoho Invoice - Invoice Maker

Zoho Invoice - Invoice Maker

Zoho Corporation

Bayer FarmRise

Bayer FarmRise

Farmrise

davaindia GENERIC PHARMACY VS.

9icembre d, 2025